Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities (Details)

v3.24.1.1.u2
Accrued expenses and other current liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Accrued expenses and other current liabilities    
Accrued clinical and development expenditure $ 12,049 $ 12,351
Accrued employee expenses 6,248 13,226
VAT Payable   1,398
Other accrued expenditure 4,113 3,277
Other 640 51
Total $ 23,050 $ 30,303